Uphar Specialty Pharma
Ahmedabad, Gujarat
Home»Products»

Alimta 100mg/500mg Inj

We are a leading wholesaler, trader and supplier of a wide range  of  Alimta
Pemetrexed
Alimta Lilly


Alimta 500MG Inj

This Drug is used in Solid Tumors but mainly used in Lung Cancer. 

Dosage Forms are : 
1)100 Mg Vial for Injection
2)500 Mg Vial for Injection

Alimta

Generic Content-Pemetrexed, Manufactured By:Eli Lilly,France

Alimta is approved for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy.



Available As: 100 Mg Injection & 500 Mg Injection



Other Information
  • Pay Mode Terms: L/C (Letter of Credit), Western Union

Alimta

We are engaged in offering Alimta, which is used in combination with cisplatin for treatment of metastatic nonsquamous non-small cell lung cancer. Our range is prescribed for the patients, whose disease has not progressed after 4 cycles of platinum-based 1st-line chemotherapy or as a single agent after prior chemotherapy. We offer these products in customized packaging and at cost effective prices to our valued clients.

 

Other Information

 

  • Pay Mode Terms: L/C (Letter of Credit), D/A (Documents against Acceptance), D/P (Documents against Payment), T/T (Bank Transfer), Western Union, Other



Other Information
  • Pay Mode Terms: L/C (Letter of Credit), D/A (Documents Against Acceptance), D/P (Documents Against Payment), Western Union, Other

Alimta

Alimta 500mg

Alimta Supplier

Alimta Lilly



Other Information
  • Pay Mode Terms: L/C (Letter of Credit), D/A (Documents Against Acceptance), D/P (Documents Against Payment), Western Union, Other
  • Port of Dispatch: Ahmedabad
  • Delivery Time: Standard Time
  • Packaging Details: 1Vial x 500mg
    1Vial x 100mg

Alimta

ALIMTA® (pemetrexed for injection) is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have different type of NSCLC called squamous cell.

To Maintain the Effect of Initial Chemotherapy Before Worsening of Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer

ALIMTA is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

If Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Returns

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

Treatment for Malignant Pleural Mesothelioma

ALIMTA is a treatment for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity. ALIMTA is given with cisplatin, another anticancer medicine (chemotherapy), when surgery is not an option.

Alimta Injection

Generic Content-Pemetrexed, Manufactured By:Eli Lilly, France

Alimtais approved for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy.


 

Uphar Specialty Pharma

Mr. Hardik Akhani (CEO)
Ground Floor, H. N. House, Near High Court Crossing, Opposite Muktajivan Color Lab, Navrangpura
Ahmedabad - 380009
Gujarat, India
© Uphar Specialty Pharma. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited